[Articles] Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study

Related Posts

• TIL-Based Combination Therapy in Metastatic Melanoma

  KEY TAKEAWAYS The TUNINTIL study phase 3 trial aimed to investigate the enhanced efficacy and…

• [Articles] Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

  TTFields therapy added to standard therapy significantly improved overall survival compared with standard therapy alone…

• ICI-Based Combo Therapy Effective in ASPSCR1-TFE3 rRCC

  KEY TAKEAWAYS The study aimed to assess the efficacy of various systemic treatments in metastatic…